Home > Journals > Minerva Urologica e Nefrologica > Past Issues > Minerva Urologica e Nefrologica 2016 February;68(1) > Minerva Urologica e Nefrologica 2016 February;68(1):14-9

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions
Cite this article as

 

REVIEW  UROLOGY 

Minerva Urologica e Nefrologica 2016 February;68(1):14-9

Copyright © 2016 EDIZIONI MINERVA MEDICA

language: English

Focus on desmopressin and enuresis: a review of literature

Pietro FERRARA 1, Flaminia VENA 2, Maria C. BASILE 2, Francesca IANNIELLO 1, Antonio GATTO 1

1 Institute of Pediatrics, Sacro Cuore Catholic University, Rome, Italy; 2 Campus Bio-Medico University, Rome, Italy


PDF


Nocturnal enuresis (NE) is a common disorder in children. Choice of treatment depends on the frequency and severity of symptoms, the child’s age and motivation. Treatment options for NE are alarm, desmopressin and imipramine. In particular, the main desmopressin therapeutical effect is the antidiuretic activity. The different formulations of desmopressin are an injectable solution, an oral tablet formulation and the recent oral lyophilisate (MELT). MELT with its higher biodisponibility guarantees the same therapy response of other formulations with a lower doses and it represents the first line and safety treatment for the NE.

top of page